Amesite, Inc. will present at The Microcap Conference 2025, discussing its NurseMagic™ app and growth strategies.
Quiver AI Summary
Amesite, Inc., a technology company focused on AI-driven B2C and B2B solutions, announced its participation in The Microcap Conference 2025 from January 28-30 at the Borgata Hotel in Atlantic City, NJ. CEO Dr. Ann Marie Sastry will present at 2:30 PM ET on January 29 and will hold meetings with investors to discuss the company’s NurseMagic™ app, which aims to enhance the efficiency of nursing professionals and home health care workers. The app includes tools for managing nursing documentation, improving patient communication, and supporting career development. Amesite's focus is on leveraging its AI infrastructure for innovative applications that meet professional and individual needs. The company also provided a cautionary note regarding forward-looking statements, highlighting that actual results could vary from anticipated outcomes.
Potential Positives
- Amesite, Inc. is participating in The Microcap Conference 2025, a significant event that provides visibility and networking opportunities with potential investors.
- Dr. Ann Marie Sastry, the CEO, will present the company's growth strategy and recent developments, highlighting leadership and transparency.
- The presentation includes information on the NurseMagic™ app, showcasing Amesite's innovation in AI-driven solutions for the healthcare industry.
- NurseMagic™ aims to enhance efficiency and support career development for nursing professionals, addressing critical needs in the healthcare sector.
Potential Negatives
- The use of the term "forward-looking statements" highlights potential risks and uncertainties surrounding the company's business plans and projections for growth, which may raise concerns among investors about the company's ability to achieve its objectives.
- The announcement does not provide significant details on the company's financial performance or user adoption metrics for the NurseMagic™ app, which could leave investors uncertain about its market traction and revenue potential.
- The reliance on participation in a conference for investor engagement may suggest a lack of other effective communication channels, raising questions about the company's overall marketing and outreach strategy.
FAQ
What is the Microcap Conference 2025?
The Microcap Conference 2025 is a major event for growth-focused companies and investors held at the Borgata Hotel Spa & Casino.
Who is Amesite's CEO?
Amesite's CEO is Dr. Ann Marie Sastry, who will deliver a presentation at the conference.
What is the NurseMagic™ app?
NurseMagic™ is an AI-powered mobile application designed to assist nursing professionals and improve their daily tasks and patient communication.
What topics will Amesite discuss at the conference?
Amesite will discuss developments related to NurseMagic™, their growth strategy, and monetization in B2C and B2B sectors.
How does Amesite utilize AI technology?
Amesite leverages proprietary AI infrastructure to develop innovative applications that address individual and professional needs in various sectors.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AMST Insider Trading Activity
$AMST insiders have traded $AMST stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AMST stock by insiders over the last 6 months:
- ANN MARIE SASTRY (CHIEF EXECUTIVE OFFICER) purchased 333,333 shares for an estimated $999,999
- GEORGE PARMER purchased 83,333 shares for an estimated $249,999
- GILBERT S OMENN purchased 3,333 shares for an estimated $9,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AMST Hedge Fund Activity
We have seen 4 institutional investors add shares of $AMST stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 12,143 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $29,750
- JPMORGAN CHASE & CO added 5,904 shares (+inf%) to their portfolio in Q3 2024, for an estimated $14,464
- UBS GROUP AG added 914 shares (+167.1%) to their portfolio in Q3 2024, for an estimated $2,239
- TOWER RESEARCH CAPITAL LLC (TRC) removed 649 shares (-53.9%) from their portfolio in Q3 2024, for an estimated $1,590
- GEODE CAPITAL MANAGEMENT, LLC added 376 shares (+2.7%) to their portfolio in Q3 2024, for an estimated $921
- BANK OF AMERICA CORP /DE/ added 1 shares (+0.6%) to their portfolio in Q3 2024, for an estimated $2
- ZUCKERMAN INVESTMENT GROUP, LLC added 0 shares (+0.0%) to their portfolio in Q3 2024, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) --
Amesite, Inc.
(Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in
The Microcap Conference 2025
, the premier event for growth-focused companies and investors. The conference is taking place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Amesite’s CEO, Dr. Ann Marie Sastry, will deliver a corporate presentation at 2:30 PM ET today, January 29, and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments with its
NurseMagic
™ app, growth strategy, and monetization in B2C and B2B pathways.
NurseMagic™ is an AI-powered mobile application designed to assist nursing professionals and home health care workers by streamlining various aspects of their daily tasks. Developed by Amesite Inc., the app offers a suite of tools aimed at enhancing efficiency, improving patient communication, and supporting career development.
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
